Gracell Bio's Unattributed VC Round

Gracell Bio raised a round of funding on September 26, 2018.

Gracell Bio (亘喜生物) is a clinical-stage biopharmaceutical company dedicated to discovering and developing cellular therapeutics for the patients suffered from hematological malignancy, solid tu…

Articles about Gracell Bio's Unattributed VC Round: